Glossary

Human-in-the-loop

What human-in-the-loop means in healthcare AI — the regulatory anchors that make it mandatory for high-stakes systems, and the automation-bias evidence that shows why nominal oversight can fail. As of July 2026.

By Jonas WeirReviewed by Jonas Weir · editorial reviewUpdated

The short version

  • Human-in-the-loop is a system design in which a person reviews, approves, or corrects an AI system's output before it takes effect.
  • In healthcare the pattern is anchored in regulation: the EU AI Act requires high-risk systems be designed for effective oversight by natural persons, and US FDA excludes CDS software from device regulation only when the clinician can independently review the basis for its recommendations.
  • Article 14 of the EU AI Act names the failure mode directly: overseers must remain aware of automation bias — the tendency to over-rely on system output.
  • A systematic review of 74 studies documented automation bias across clinical decision support settings — a human being present differs from a human effectively checking.
  • Oversight is work: in a roughly 1,800-clinician scribe study where every AI-drafted note required review, only 32% of users adopted the tool for more than half their visits. As of July 2026.

Human-in-the-loop (HITL) is a system design in which a person reviews, approves, or corrects an AI system's output before it takes effect. In healthcare it keeps a qualified clinician's judgment between the model and the patient: the system drafts, flags, or recommends — a human decides.

Why does human-in-the-loop matter in healthcare?

The pattern is anchored in regulation on both sides of the Atlantic. The EU AI Act requires that high-risk AI systems — a category that captures most clinical uses — be designed so they "can be effectively overseen by natural persons during the period in which they are in use" 1. In the United States, FDA excludes a clinical decision support system from device regulation only when, among other criteria, the software enables the clinician to independently review the basis for its recommendations rather than rely on them primarily 2. WHO's guidance on large multi-modal models points the same direction, warning against deployments that leave model output unchecked 3.

How does human-in-the-loop work in practice?

Two grades of the pattern recur. In-the-loop: a person acts on every output — the ambient-scribe workflow, where the clinician edits and signs each AI-drafted note before it enters the record. On-the-loop: a person monitors a running system and intervenes on exception — the posture emerging around agentic AI in healthcare, where an agent executes multi-step tasks under supervision.

The design question is never merely whether a human sits in the loop, but whether that human can actually catch errors. The EU AI Act names the threat directly: overseers must "remain aware of the possible tendency of automatically relying or over-relying on the output" — automation bias 1. That awareness clause exists because the failure is well-documented: a systematic review of 74 studies recorded automation bias — the tendency to over-rely on automation — across clinical decision support settings, with mitigators including training, accountability, and interface design 4. WHO repeats the warning for large multi-modal models, noting they may encourage automation bias whereby errors are overlooked that would otherwise have been identified 3.

Where does human-in-the-loop appear today?

As of July 2026, the most visible HITL workflow in healthcare is ambient documentation. In a roughly 1,800-clinician study, every AI-drafted note required clinician review before signing; daily EHR time fell by about 13 minutes and documentation time by about 16 — yet only 32% of users adopted the tool for more than half their visits 5. The numbers carry the lesson: review is real work, and the loop's cost shows up in adoption depth. Cross-domain figures sit in our AI in healthcare statistics.

Common misunderstandings

A human present equals a human in control. Automation bias means a reviewer under time pressure can rubber-stamp output they would have corrected unaided 4. Effective oversight has to be designed — prominence of evidence, accountability, workload — rather than assumed.

HITL is free. Reviewing every output consumes clinician time. Measured time savings from ambient scribes are modest partly because the loop itself absorbs minutes 5.

HITL removes the need to fix the model. Review catches errors like AI hallucination imperfectly; the control works best when error rates are already low.

Related terms

A clinical decision support system is the oldest HITL pattern in healthcare. AI hallucination in clinical contexts is the failure mode review exists to catch. Agentic AI is where the loop is being renegotiated, as of July 2026.

Questions & answers

  • Is human-in-the-loop legally required for healthcare AI?

    Increasingly, yes — by design requirement rather than by that exact name. The EU AI Act requires high-risk AI systems to be designed so natural persons can effectively oversee them in use, and US FDA excludes clinical decision support software from device regulation only when the clinician can independently review the basis for its recommendations.

  • What is the difference between human-in-the-loop and human-on-the-loop?

    In-the-loop means a person acts on each individual output — reviewing and signing every AI-drafted note, for example. On-the-loop means a person monitors the running system and intervenes when needed, without touching every output. Healthcare deployments published to date overwhelmingly use the stricter in-the-loop pattern.

  • Does having a human in the loop guarantee safety?

    No — automation bias, the documented tendency to over-rely on automated advice, means a nominal reviewer can wave through errors they would have caught unaided. The EU AI Act explicitly requires overseers to remain aware of this tendency, and mitigations include training, accountability, and interface design.

Sources

  1. Regulation (EU) 2024/1689 of the European Parliament and of the Council (Artificial Intelligence Act), Article 14: Human oversight. Official Journal of the European Union. 12 July 2024. eur-lex.europa.eu/eli/reg/2024/1689/oj
  2. US Food and Drug Administration. Clinical Decision Support Software — Guidance for Industry and FDA Staff. Revised final guidance, January 2026. www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software
  3. World Health Organization. Ethics and governance of artificial intelligence for health: Guidance on large multi-modal models. Geneva: WHO; 18 January 2024. www.who.int/publications/i/item/9789240084759
  4. Goddard K, Roudsari A, Wyatt JC. Automation bias: a systematic review of frequency, effect mediators, and mitigators. Journal of the American Medical Informatics Association. 2012;19(1):121-127. doi.org/10.1136/amiajnl-2011-000089
  5. Changes in Clinician Time Expenditure and Visit Quantity With Adoption of Artificial Intelligence–Powered Scribes. JAMA. 2026. doi.org/10.1001/jama.2026.2253